Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

915 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of Heterozygosity.
Witter K, Reibke R, Subklewe M, Zahn R, Kauke T, Spiekermann K, Spannagl M, Tischer J, Hiddemann W, Dick A. Witter K, et al. Among authors: hiddemann w. Bone Marrow Res. 2014;2014:541345. doi: 10.1155/2014/541345. Epub 2014 Apr 3. Bone Marrow Res. 2014. PMID: 24860670 Free PMC article.
Second haematopoietic SCT using HLA-haploidentical donors in patients with relapse of acute leukaemia after a first allogeneic transplantation.
Tischer J, Engel N, Fritsch S, Prevalsek D, Hubmann M, Schulz C, Zoellner AK, Bücklein V, Lippl S, Reibke R, Rieger CT, Ledderose G, Stemmler HJ, Hiddemann W, Schmid C, Hausmann A. Tischer J, et al. Among authors: hiddemann w. Bone Marrow Transplant. 2014 Jul;49(7):895-901. doi: 10.1038/bmt.2014.83. Epub 2014 May 12. Bone Marrow Transplant. 2014. PMID: 24820212
Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphoma.
Zoellner AK, Fritsch S, Prevalsek D, Engel N, Hubmann M, Reibke R, Rieger CT, Hellmuth JC, Haas M, Mumm F, Herold T, Ledderose G, Hiddemann W, Dreyling M, Hausmann A, Tischer J. Zoellner AK, et al. Among authors: hiddemann w. Bone Marrow Transplant. 2015 May;50(5):679-84. doi: 10.1038/bmt.2014.328. Epub 2015 Feb 2. Bone Marrow Transplant. 2015. PMID: 25642765 Clinical Trial.
Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot study.
Schmid C, Schleuning M, Tischer J, Holler E, Haude KH, Braess J, Haferlach C, Baurmann H, Oruzio D, Hahn J, Spiekermann K, Schlimok G, Schwerdtfeger R, Buechner T, Hiddemann W, Kolb HJ. Schmid C, et al. Among authors: hiddemann w. Bone Marrow Transplant. 2012 Jan;47(1):46-53. doi: 10.1038/bmt.2011.15. Epub 2011 Feb 28. Bone Marrow Transplant. 2012. PMID: 21358688 Clinical Trial.
CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cell-engaging antibody AMG 330.
Krupka C, Kufer P, Kischel R, Zugmaier G, Bögeholz J, Köhnke T, Lichtenegger FS, Schneider S, Metzeler KH, Fiegl M, Spiekermann K, Baeuerle PA, Hiddemann W, Riethmüller G, Subklewe M. Krupka C, et al. Among authors: hiddemann w. Blood. 2014 Jan 16;123(3):356-65. doi: 10.1182/blood-2013-08-523548. Epub 2013 Dec 3. Blood. 2014. PMID: 24300852 Free article.
The role of therapeutic leukapheresis in hyperleukocytotic AML.
Pastore F, Pastore A, Wittmann G, Hiddemann W, Spiekermann K. Pastore F, et al. Among authors: hiddemann w. PLoS One. 2014 Apr 14;9(4):e95062. doi: 10.1371/journal.pone.0095062. eCollection 2014. PLoS One. 2014. PMID: 24733550 Free PMC article.
A fluorescence in situ hybridization-based screen allows rapid detection of adverse cytogenetic alterations in patients with acute myeloid leukemia.
Sandhöfer N, Metzeler KH, Kakadia PM, Pasalic Z, Hiddemann W, Neusser M, Steinlein O, Fiegl M, Subklewe M, Spiekermann K, Bohlander SK, Schneider S, Braess J. Sandhöfer N, et al. Among authors: hiddemann w. Genes Chromosomes Cancer. 2017 Aug;56(8):632-638. doi: 10.1002/gcc.22466. Epub 2017 May 19. Genes Chromosomes Cancer. 2017. PMID: 28420034
[Molecular target structures in oncology].
Spiekermann K, Hiddemann W. Spiekermann K, et al. Among authors: hiddemann w. Internist (Berl). 2005 Aug;46(8):847-8, 850-4, 856-60. doi: 10.1007/s00108-005-1463-0. Internist (Berl). 2005. PMID: 16007411 Review. German.
High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission.
Schmid C, Schleuning M, Hentrich M, Markl GE, Gerbitz A, Tischer J, Ledderose G, Oruzio D, Hiddemann W, Kolb HJ. Schmid C, et al. Among authors: hiddemann w. Bone Marrow Transplant. 2008 Apr;41(8):721-7. doi: 10.1038/sj.bmt.1705965. Epub 2008 Jan 7. Bone Marrow Transplant. 2008. PMID: 18176613
915 results